Pharmacists in Ayer, MA Accepting Medicare

5 Pharmacists found. Showing 1 - 5

Mr. Martin Chukwukeluo Nwabueze, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Main St, Ayer, MA 01432 Phone: 978-772-7325

Sokankelly Lim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13 Park St, Ayer, MA 01432 Phone: 978-391-4061    Fax: 978-391-4586

Caroline Santos, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13 Park St, Ayer, MA 01432 Phone: 978-391-4061    Fax: 978-391-4586

Mrs. Paula Gravelle, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39 Calvin St, Ayer, MA 01432 Phone: 978-490-1067

Dean J. Overmiller, PHARM.D. Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 42 Patton Rd, Ayer, MA 01434 Phone: 978-796-1560

News Archive

Mundus studies potential for VTOL UAV against Malaria

Mundus Group Inc., studies potential for VTOL UAV to provide increased capabilities in fight against Malaria and disease spread through mosquitoes with precision aerial laser eradication treatments.

Cellectricon, Neusentis to host webinar on phenotypic screening approaches in pain research

Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with Neusentis, describing the use of native cells to develop an assay with improved physiological relevance over traditional approaches in pain drug discovery research.

Sen. Baucus tells single-payer advocates he regrets there wasn't more discussion of single-payer plan

Senate Finance Committee Chairman Max Baucus, D-Mont., told single-payer advocates Wednesday that he regrets not allowing more discussion of the single-payer plan in his efforts to draft a health system overhaul proposal, according to participants at the meeting.

Study raises questions about direct applicability of clinical trial data for cancer drugs

When prescribing newly approved drugs, physicians rely on data from clinical trials to understand the benefits and risks of those drugs for patients. But a study published in the Journal of Oncology Practice showed that for certain cancer drugs, participants in clinical trials are often not representative of the patients that ultimately take the drugs, raising questions about the direct applicability of trial data.

Read more Medical News

› Verified 9 days ago